Company registration number 10000831 (England and Wales)
LONDON CARDIOLOGY GROUP LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
LONDON CARDIOLOGY GROUP LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
LONDON CARDIOLOGY GROUP LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
4
10,314
20,734
Investments
5
57,860
31,116
68,174
51,850
Current assets
Debtors
6
630,952
657,862
Investments
7
743,802
612,462
Cash at bank and in hand
244,912
140,407
1,619,666
1,410,731
Creditors: amounts falling due within one year
8
(115,624)
(125,110)
Net current assets
1,504,042
1,285,621
Net assets
1,572,216
1,337,471
Capital and reserves
Called up share capital
200
200
Profit and loss reserves
1,572,016
1,337,271
Total equity
1,572,216
1,337,471

For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 18 September 2025 and are signed on its behalf by:
Dr P B Lim
Ms W L Chan
Director
Director
Company registration number 10000831 (England and Wales)
LONDON CARDIOLOGY GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
1
Accounting policies
Company information

London Cardiology Group Limited is a private company limited by shares incorporated in England and Wales. The registered office is 7 Lindum Terrace, Lincoln, Lincolnshire, England, LN2 5RP.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention.The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover represents trading income accrued during the period shown by the financial statements.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
33% straight line
Motor vehicles
20% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Basic financial assets

Basic financial assets include short-term liquid investments with original maturities of three months or less.

1.5
Taxation

The tax expense represents the sum of the tax currently payable.

LONDON CARDIOLOGY GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 3 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.6
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
2
2
LONDON CARDIOLOGY GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2024
61,956
Additions
280
At 31 December 2024
62,236
Depreciation and impairment
At 1 January 2024
41,222
Depreciation charged in the year
10,700
At 31 December 2024
51,922
Carrying amount
At 31 December 2024
10,314
At 31 December 2023
20,734
5
Fixed asset investments
2024
2023
£
£
Other investments
57,860
31,116
Fixed asset investments not carried at market value
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 January 2024
31,116
Additions
26,744
At 31 December 2024
57,860
Carrying amount
At 31 December 2024
57,860
At 31 December 2023
31,116
LONDON CARDIOLOGY GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 5 -
6
Debtors
2024
2023
Amounts falling due within:
£
£
one year
Trade debtors
38,785
95,300
after more than one year
Other debtors
592,167
562,562
630,952
657,862
7
Current asset investments
2024
2023
£
£
Other investments
743,802
612,462
8
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
5,957
3,179
Corporation tax
101,829
96,120
Other creditors
7,838
25,811
115,624
125,110
2024-12-312024-01-01falsefalsefalse18 September 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityDr P B LimMs W L Chan100008312024-01-012024-12-31100008312024-12-31100008312023-12-3110000831core:OtherPropertyPlantEquipment2024-12-3110000831core:OtherPropertyPlantEquipment2023-12-3110000831core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3110000831core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3110000831core:CurrentFinancialInstruments2024-12-3110000831core:CurrentFinancialInstruments2023-12-3110000831core:ShareCapital2024-12-3110000831core:ShareCapital2023-12-3110000831core:RetainedEarningsAccumulatedLosses2024-12-3110000831core:RetainedEarningsAccumulatedLosses2023-12-3110000831bus:Director12024-01-012024-12-3110000831bus:Director22024-01-012024-12-3110000831core:ComputerEquipment2024-01-012024-12-3110000831core:MotorVehicles2024-01-012024-12-31100008312023-01-012023-12-3110000831core:OtherPropertyPlantEquipment2023-12-3110000831core:OtherPropertyPlantEquipment2024-01-012024-12-3110000831core:WithinOneYear2024-12-3110000831core:WithinOneYear2023-12-3110000831bus:PrivateLimitedCompanyLtd2024-01-012024-12-3110000831bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3110000831bus:FRS1022024-01-012024-12-3110000831bus:AuditExemptWithAccountantsReport2024-01-012024-12-3110000831bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP